Lumida
/FHTX
⌘K
Foghorn Therapeutics Inc

Foghorn Therapeutics Inc

FHTX
$5.19USD+2.37%+0.12 today

MARKET CAP

304.7M

P/E (TTM)

FWD P/E

DAY RANGE

$5 – $5

52W RANGE

$3
$7

AI Summary

Stalk
TrimMedium

FHTX remains in a prolonged Stage 4 decline under sustained lower highs and lower lows with EMAs sloping downward and acting as resistance. The active Bearish Exhaustion pattern signals sellers losing control and increases the probability of a bottoming attempt or reversal bounce. Despite extreme oversold readings, lack of sustained reversal suggests selling is best deferred. Favor trimming on rallies into declining EMA regions or prior support-turned-resistance zones for structurally aligned execution.

  • Analyst price target $11.44 implies ~90% upside from $6.01
  • Return on equity at 85.8% indicates robust capital returns
  • Q2 revenue $3.27 M vs $7.94 M estimate highlights sales shortfall
Full analysis →
Insider Trades10 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Apr 9, 2026SellFHTXAdrian GottschalkChief Executive Officer213,410$4.79$304.7M-25.32%+58.72%$1.0M+0.00%Trim
Apr 25, 2025SellFHTXAdrian GottschalkChief Executive Officer600,000$4.36$304.7M-25.32%+58.72%$2.6M+0.00%Trim
Apr 9, 2025SellFHTXAdrian GottschalkChief Executive Officer395,812$3.54$304.7M-25.32%+58.72%$1.4M+0.00%Trim
Sep 20, 2024SellFHTXCarlos CostaChief People Officer73,226$6.88$304.7M-25.32%+58.72%$503.9K+0.00%10b5-1Trim
Sep 18, 2024SellFHTXCarlos CostaChief People Officer23,148$6.89$304.7M-25.32%+58.72%$159.4K+0.00%10b5-1Trim
Sep 16, 2024SellFHTXCarlos CostaChief People Officer21,344$6.88$304.7M-25.32%+58.72%$146.8K+0.00%10b5-1Trim
Sep 9, 2024SellFHTXSteven F. BellonChief Scientific Officer20,000$9.50$304.7M-25.32%+58.72%$190.0K-16.40%10b5-1Trim
Mar 11, 2024SellFHTXFanny CavalieChief Strategy/Bus Ops Officer11,000$6.56$304.7M-25.32%+58.72%$72.1K-12.64%Trim
Aug 17, 2023SellFHTXAdrian GottschalkChief Executive Officer126,000$8.62$304.7M-25.32%+58.72%$1.1M+0.00%Trim
Aug 16, 2023SellFHTXSamuel AgrestaChief Medical Officer622,594$5.98$304.7M-25.32%+58.72%$3.7M+0.00%Trim